- Hyperfractionated radiotherapy concomitant with cisplatin and granulocyte colony-stimulating factor (filgrastim) for laryngeal carcinomaM Tejedor
Department of Oncology, Hospital de Navarra, Pamplona, Spain
Cytokines Cell Mol Ther 6:35-9. 2000..Overall survival was 55% at three years. The administration of filgrastim with this regimen was feasible, and it appeared to reduce the severity and duration of mucositis induced by the combined treatment...